-
1
-
-
0027131831
-
Newer insights into cisplatin nephrotoxicity
-
1. Anand AJ, Bashey B: Newer insights into cisplatin nephrotoxicity. Ann Pharmacother 27:1519-1527, 1993
-
(1993)
Ann Pharmacother
, vol.27
, pp. 1519-1527
-
-
Anand, A.J.1
Bashey, B.2
-
2
-
-
0001218786
-
Cisplatin nephrotoxicity: Physiological and biochemical aspects
-
edited by McBrien DCH, Slater TF, Oxford, IRL Press
-
2. Safirstein R, Winston J, Guttenplan J: Cisplatin nephrotoxicity: Physiological and biochemical aspects, in Biochemical Mechanisms of Platinum Antitumor Drugs, edited by McBrien DCH, Slater TF, Oxford, IRL Press, 1986, pp 271-306
-
(1986)
Biochemical Mechanisms of Platinum Antitumor Drugs
, pp. 271-306
-
-
Safirstein, R.1
Winston, J.2
Guttenplan, J.3
-
3
-
-
0026530540
-
Role of vascular congestion in cisplatin-induced acute renal failure in the rat
-
3. Luke DR, Vadiei K, Lopez-Berestein G: Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 7:1-7, 1992
-
(1992)
Nephrol Dial Transplant
, vol.7
, pp. 1-7
-
-
Luke, D.R.1
Vadiei, K.2
Lopez-Berestein, G.3
-
4
-
-
0022134205
-
Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat
-
4. Winston JA, Safirstein R: Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol 249:F490-F496, 1985
-
(1985)
Am J Physiol
, vol.249
-
-
Winston, J.A.1
Safirstein, R.2
-
5
-
-
0022903795
-
Protective effects of 0-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat
-
5. Dobyan DC, Bull JM, Strebel FR, Sunderland BA, Bulger RE: Protective effects of 0-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat. Lab Invest 55:557 563, 1986
-
(1986)
Lab Invest
, vol.55
, pp. 557
-
-
Dobyan, D.C.1
Bull, J.M.2
Strebel, F.R.3
Sunderland, B.A.4
Bulger, R.E.5
-
6
-
-
0025021730
-
Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells
-
6. Tamatani T, Miyasaka M: Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 2:165-171, 1990
-
(1990)
Int Immunol
, vol.2
, pp. 165-171
-
-
Tamatani, T.1
Miyasaka, M.2
-
7
-
-
0024327746
-
Nucleotide sequence of the cDNA for murine intercellular adhesion molecule-1 (ICAM-1)
-
7. Ballantyne CM, O'Brien WE, Beudei AL: Nucleotide sequence of the cDNA for murine intercellular adhesion molecule-1 (ICAM-1). Nucleic Acid Res 17:5853, 1989
-
(1989)
Nucleic Acid Res
, vol.17
, pp. 5853
-
-
Ballantyne, C.M.1
O'Brien, W.E.2
Beudei, A.L.3
-
8
-
-
0030067639
-
Intercellular adhesion molecule-1 deficient mice are protected against ischemic renal injury
-
8. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutiérrez-Ramos J-C, Bonventre JV: Intercellular adhesion molecule-1 deficient mice are protected against ischemic renal injury. J Clin Invest 97:1056-1063, 1996
-
(1996)
J Clin Invest
, vol.97
, pp. 1056-1063
-
-
Kelly, K.J.1
Williams W.W., Jr.2
Colvin, R.B.3
Meehan, S.M.4
Springer, T.A.5
Gutiérrez-Ramos, J.-C.6
Bonventre, J.V.7
-
9
-
-
0030117467
-
Biodistribution of indium-111-labeled antibody directed against intercellular adhesion molecule-1
-
9. Sasso D, Gionfriddo M, Thrall R, Syrbu S, Smilowitz H, Weiner R: Biodistribution of indium-111-labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med 37:656-661, 1996
-
(1996)
J Nucl Med
, vol.37
, pp. 656-661
-
-
Sasso, D.1
Gionfriddo, M.2
Thrall, R.3
Syrbu, S.4
Smilowitz, H.5
Weiner, R.6
-
10
-
-
0020051148
-
Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
-
10. Bradlfy PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209, 1982
-
(1982)
J Invest Dermatol
, vol.78
, pp. 206-209
-
-
Bradlfy, P.P.1
Priebat, D.A.2
Christensen, R.D.3
Rothstein, G.4
-
11
-
-
0028039822
-
Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury
-
11. Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91:812-816, 1994
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 812-816
-
-
Kelly, K.J.1
Williams, W.W.2
Colvin, R.B.3
Bonventre, J.V.4
-
12
-
-
0024425253
-
Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF
-
12. Safirstein R, Zelent AZ, Price PM: Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int 36:810-815, 1989
-
(1989)
Kidney Int
, vol.36
, pp. 810-815
-
-
Safirstein, R.1
Zelent, A.Z.2
Price, P.M.3
-
13
-
-
0021348863
-
Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function
-
13. Offerman J, Meijer S, Sleijfer D, Mulder N, Donker A, Koops H, Van Der Hem G: Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function. Cancer Chemother Pharmacol 12:36-38, 1984
-
(1984)
Cancer Chemother Pharmacol
, vol.12
, pp. 36-38
-
-
Offerman, J.1
Meijer, S.2
Sleijfer, D.3
Mulder, N.4
Donker, A.5
Koops, H.6
Van Der Hem, G.7
-
14
-
-
0009738754
-
Protection against ischemic renal injury with blockade of intercellular adhesion molecule-1
-
edited by Goligorsky M, New York, Churchill Livingstone
-
14. Kelly K, Bonventre J: Protection against ischemic renal injury with blockade of intercellular adhesion molecule-1, in Acute Renal Failure: New Concepts and Therapeutic Strategies, edited by Goligorsky M, New York, Churchill Livingstone, 1995, pp 401-423
-
(1995)
Acute Renal Failure: New Concepts and Therapeutic Strategies
, pp. 401-423
-
-
Kelly, K.1
Bonventre, J.2
-
15
-
-
0025266439
-
Cisplatin nephrotoxicity: Experimental and clinical studies
-
15. Daugaard G: Cisplatin nephrotoxicity: Experimental and clinical studies. Dan Med Bull 37:1-12, 1990
-
(1990)
Dan Med Bull
, vol.37
, pp. 1-12
-
-
Daugaard, G.1
-
16
-
-
0017686755
-
The renal pathology in clinical trials of cis-platinum (II) diamminedichloride
-
16. Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS: The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 39:1362-1371, 1977
-
(1977)
Cancer
, vol.39
, pp. 1362-1371
-
-
Gonzales-Vitale, J.C.1
Hayes, D.M.2
Cvitkovic, E.3
Sternberg, S.S.4
-
17
-
-
0026459790
-
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron
-
17. Coates AS, Childs A, Cox K, Forsyth C, Joshua DE, McNeil E, Grygiel JJ: Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron. Ann Oncol 3:719-722, 1992
-
(1992)
Ann Oncol
, vol.3
, pp. 719-722
-
-
Coates, A.S.1
Childs, A.2
Cox, K.3
Forsyth, C.4
Joshua, D.E.5
McNeil, E.6
Grygiel, J.J.7
-
18
-
-
0019603599
-
Cisplatin nephrotoxicity in rats: Defect in papillary hypertonicity
-
18. Safirstein R, Miller P, Dikman S, Lyman N, Shapiro C: Cisplatin nephrotoxicity in rats: Defect in papillary hypertonicity. Am J Physiol 241:F175-F185, 1981
-
(1981)
Am J Physiol
, vol.241
-
-
Safirstein, R.1
Miller, P.2
Dikman, S.3
Lyman, N.4
Shapiro, C.5
-
19
-
-
0015894421
-
Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel
-
19. Kovach J, Moertel C, Schutt A, Rettmeier R, Hahn R: Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Cancer Chemother Rep 57:357-359, 1973
-
(1973)
Cancer Chemother Rep
, vol.57
, pp. 357-359
-
-
Kovach, J.1
Moertel, C.2
Schutt, A.3
Rettmeier, R.4
Hahn, R.5
-
20
-
-
0026052770
-
Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity
-
20. Dos Santos OF, Boim MA, Barros EJ, Schor N: Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity. Kidney Int 40:742-747, 1991
-
(1991)
Kidney Int
, vol.40
, pp. 742-747
-
-
Dos Santos, O.F.1
Boim, M.A.2
Barros, E.J.3
Schor, N.4
-
21
-
-
0022999159
-
Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin
-
21. Lam M, Adelstein DJ: Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin. Am J Kidney Dis 8:164-169, 1986
-
(1986)
Am J Kidney Dis
, vol.8
, pp. 164-169
-
-
Lam, M.1
Adelstein, D.J.2
-
22
-
-
0022369534
-
Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats
-
22. Mavichak V, Wong NL, Quammf GA, Magil AB, Sutton RA, Dirks JH: Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats. Kidney Int 28:914-921, 1985
-
(1985)
Kidney Int
, vol.28
, pp. 914-921
-
-
Mavichak, V.1
Wong, N.L.2
Quammf, G.A.3
Magil, A.B.4
Sutton, R.A.5
Dirks, J.H.6
-
23
-
-
0023749761
-
Renal tubular functions in patients treated with high-dose cisplatin
-
23. Daugaard G, Abildgaard U, Holstein-Raihlou N-H, Bruunshuus I, Bucher D, Layssac P: Renal tubular functions in patients treated with high-dose cisplatin. Clin Pharmacol Ther 44:164-172, 1988
-
(1988)
Clin Pharmacol Ther
, vol.44
, pp. 164-172
-
-
Daugaard, G.1
Abildgaard, U.2
Holstein-Raihlou, N.-H.3
Bruunshuus, I.4
Bucher, D.5
Layssac, P.6
-
24
-
-
0031005532
-
Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells
-
24. Combe C, Burton C, Dufourco P, Weston S, Horsburgh T, Walls J, Harris K: Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells. Kidney Int 51:1703-1709, 1997
-
(1997)
Kidney Int
, vol.51
, pp. 1703-1709
-
-
Combe, C.1
Burton, C.2
Dufourco, P.3
Weston, S.4
Horsburgh, T.5
Walls, J.6
Harris, K.7
-
25
-
-
0030045755
-
HLA-DR class II and ICAM-1 expression on tubular cells taken by fine-needle biopsy in renal allograft dysfunction
-
25. Gonzalez-Posada J, Garcia-Castro M, Tamajon L, Torres A, Hernandez D, Losada M, Maceira B, Salido E: HLA-DR class II and ICAM-1 expression on tubular cells taken by fine-needle biopsy in renal allograft dysfunction. Nephrol Dial Transplant 11:148-152, 1996
-
(1996)
Nephrol Dial Transplant
, vol.11
, pp. 148-152
-
-
Gonzalez-Posada, J.1
Garcia-Castro, M.2
Tamajon, L.3
Torres, A.4
Hernandez, D.5
Losada, M.6
Maceira, B.7
Salido, E.8
-
26
-
-
84940136598
-
Functional and histopathological changes in dog kidneys after administration of cisplatin
-
26. Daugaard G, Abildgaard U, Holstein-Rathlou N-H, Leyssac P, Amtorp O, Olesen H, Leyssac P: Functional and histopathological changes in dog kidneys after administration of cisplatin. Renal Physiol 10:54-64, 1987
-
(1987)
Renal Physiol
, vol.10
, pp. 54-64
-
-
Daugaard, G.1
Abildgaard, U.2
Holstein-Rathlou, N.-H.3
Leyssac, P.4
Amtorp, O.5
Olesen, H.6
Leyssac, P.7
-
28
-
-
0009668706
-
Acute effect of cis-diamminedichloroplatinum on renal blood flow and glomerular filtration rate in dogs
-
edited by Bach PH, Lock EA, London, Wiley
-
28. Daugaard G, Abildgaard U, Amtorp O: Acute effect of cis-diamminedichloroplatinum on renal blood flow and glomerular filtration rate in dogs, in Renal Heterogeneity and Target Cell Toxicity, edited by Bach PH, Lock EA, London, Wiley, 1985, pp 401-404
-
(1985)
Renal Heterogeneity and Target Cell Toxicity
, pp. 401-404
-
-
Daugaard, G.1
Abildgaard, U.2
Amtorp, O.3
-
29
-
-
0024599165
-
Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activity
-
29. Sugiyama S, Hayakawa M, Kato T, Hanaki Y, Shimizu K, Ozawa T: Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activity. Biochem Biophys Res Commun 159:1121-1127, 1989
-
(1989)
Biochem Biophys Res Commun
, vol.159
, pp. 1121-1127
-
-
Sugiyama, S.1
Hayakawa, M.2
Kato, T.3
Hanaki, Y.4
Shimizu, K.5
Ozawa, T.6
-
30
-
-
0020436650
-
Early polyuria in the rat following single dose cis-diammine platinum (II)
-
30. Clifton G, Pearce C, O'Neill W, Wallin J: Early polyuria in the rat following single dose cis-diammine platinum (II). J Lab Clin Med 100:659-670, 1982
-
(1982)
J Lab Clin Med
, vol.100
, pp. 659-670
-
-
Clifton, G.1
Pearce, C.2
O'Neill, W.3
Wallin, J.4
-
31
-
-
0024349631
-
Cisplatin-induced changes in cytochrome P-450, lipid peroxidation and drug-metabolizing enzyme activities in rat kidney cortex
-
31. Bompart G: Cisplatin-induced changes in cytochrome P-450, lipid peroxidation and drug-metabolizing enzyme activities in rat kidney cortex. Toxicol Lett 48:193-199, 1989
-
(1989)
Toxicol Lett
, vol.48
, pp. 193-199
-
-
Bompart, G.1
-
32
-
-
0023836581
-
Stimulation of the renal endoplasmic reticulum calcium pump: A possible biomarker for platinate toxicity
-
32. DeWitt LM, Jones TW, Moore L: Stimulation of the renal endoplasmic reticulum calcium pump: A possible biomarker for platinate toxicity. Toxicol Appl Pharmacol 92:157-169, 1988
-
(1988)
Toxicol Appl Pharmacol
, vol.92
, pp. 157-169
-
-
DeWitt, L.M.1
Jones, T.W.2
Moore, L.3
-
33
-
-
0028204153
-
Effect of calcium channel blockers on intercellular calcium accumulation
-
33. Haag-Weber M, Horl W: Effect of calcium channel blockers on intercellular calcium accumulation. Nephrol Dial Transplant 9(Suppl 3):24-27, 1994
-
(1994)
Nephrol Dial Transplant
, vol.9
, Issue.SUPPL. 3
, pp. 24-27
-
-
Haag-Weber, M.1
Horl, W.2
-
34
-
-
0023637189
-
Cisplatin nephrotoxicity: In vitro studies with precision-cut rabbit renal cortical slices
-
34. Phelps J, Gandolfi A, Brendel K, Dorr R: Cisplatin nephrotoxicity: In vitro studies with precision-cut rabbit renal cortical slices. Toxicol Appl Pharmacol 90:501-512, 1987
-
(1987)
Toxicol Appl Pharmacol
, vol.90
, pp. 501-512
-
-
Phelps, J.1
Gandolfi, A.2
Brendel, K.3
Dorr, R.4
-
35
-
-
0021913272
-
High-dose cisplatin with sodium thiosulfate protection
-
35. Pfeifle C, Howell S, Felthouse R, Woliver T, Andrews P, Markman M, Murphy M: High-dose cisplatin with sodium thiosulfate protection. J Clin Oncol 3:232-244, 1985
-
(1985)
J Clin Oncol
, vol.3
, pp. 232-244
-
-
Pfeifle, C.1
Howell, S.2
Felthouse, R.3
Woliver, T.4
Andrews, P.5
Markman, M.6
Murphy, M.7
-
36
-
-
0019129606
-
Effect of sodium thiosulfate on cis-dichlorodiammineplatinum (II) toxicity and antitumor activity in L1210 leukemia
-
36. Howell SB, Taetle R: Effect of sodium thiosulfate on cis-dichlorodiammineplatinum (II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64:611-616, 1980
-
(1980)
Cancer Treat Rep
, vol.64
, pp. 611-616
-
-
Howell, S.B.1
Taetle, R.2
-
37
-
-
0024402241
-
Clinical trials of WR-2721 and cis-platinum
-
37. Glover D, Grabelsky S, Fox K, Weiler C, Cannon L, Glick J: Clinical trials of WR-2721 and cis-platinum. Int J Radiat Oncol Biol Phys 16:1201-1204, 1989
-
(1989)
Int J Radiat Oncol Biol Phys
, vol.16
, pp. 1201-1204
-
-
Glover, D.1
Grabelsky, S.2
Fox, K.3
Weiler, C.4
Cannon, L.5
Glick, J.6
-
38
-
-
0025689645
-
Pharmacological interventions to reduce platinum-induced toxicity
-
38. Tognella S: Pharmacological interventions to reduce platinum-induced toxicity. Cancer Treat Rev 17:139-142, 1990
-
(1990)
Cancer Treat Rev
, vol.17
, pp. 139-142
-
-
Tognella, S.1
-
39
-
-
0025731798
-
The use of probenecid as a chemoprotector against cisplatin nephrotoxicity
-
39. Jacobs C, Kaubisch S, Halsey J, Lum BL, Gosland M, Colman CN, Sikic BI: The use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer 67:1518-1524, 1991
-
(1991)
Cancer
, vol.67
, pp. 1518-1524
-
-
Jacobs, C.1
Kaubisch, S.2
Halsey, J.3
Lum, B.L.4
Gosland, M.5
Colman, C.N.6
Sikic, B.I.7
-
40
-
-
0021868065
-
Cisplatin nephrotoxicity: A summary of preventative interventions
-
40. Finley R, Fortner C, Grove W: Cisplatin nephrotoxicity: A summary of preventative interventions. Drug Intell Clin Pharm 19:362-367, 1985
-
(1985)
Drug Intell Clin Pharm
, vol.19
, pp. 362-367
-
-
Finley, R.1
Fortner, C.2
Grove, W.3
-
41
-
-
0025861520
-
Role of nitric oxide in renal medullary oxygenation
-
41. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S: Role of nitric oxide in renal medullary oxygenation.J Clin Invest 88:390-395, 1991
-
(1991)
J Clin Invest
, vol.88
, pp. 390-395
-
-
Brezis, M.1
Heyman, S.N.2
Dinour, D.3
Epstein, F.H.4
Rosen, S.5
-
42
-
-
0025368279
-
An in vitro model of ischemia/reperfusion-induced microvascular injury
-
42. Inauen W, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR: An in vitro model of ischemia/reperfusion-induced microvascular injury. Am J Physiol 259:G134-G139, 1990
-
(1990)
Am J Physiol
, vol.259
-
-
Inauen, W.1
Granger, D.N.2
Meininger, C.J.3
Schelling, M.E.4
Granger, H.J.5
Kvietys, P.R.6
-
43
-
-
0009736455
-
Neutrophil-derived oxygen radicals in myocardial reperfusion injury
-
edited by Zelenock GB, St. Louis, C.V. Mosby Company
-
43. Lucchesi BR: Neutrophil-derived oxygen radicals in myocardial reperfusion injury, in Clinical Ischemic Syndromes, edited by Zelenock GB, St. Louis, C.V. Mosby Company, 1990, pp 257-275
-
(1990)
Clinical Ischemic Syndromes
, pp. 257-275
-
-
Lucchesi, B.R.1
-
44
-
-
0025819503
-
Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia
-
44. Lefer AM, Tsao PS, Lefer DJ, Ma X-L: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia, FASEB J 5:2029-2034, 1991
-
(1991)
FASEB J
, vol.5
, pp. 2029-2034
-
-
Lefer, A.M.1
Tsao, P.S.2
Lefer, D.J.3
Ma, X.-L.4
-
45
-
-
0026051453
-
Effects of dietary ω3 fatty acids on vascular contractility in preanoxic and postanoxic aortic rings
-
45. Malis CD, Leaf A, Varadarajan GS, Newell JB, Weber PC, Force T, Bonventre JV: Effects of dietary ω3 fatty acids on vascular contractility in preanoxic and postanoxic aortic rings. Circulation 84:1393-1401, 1991
-
(1991)
Circulation
, vol.84
, pp. 1393-1401
-
-
Malis, C.D.1
Leaf, A.2
Varadarajan, G.S.3
Newell, J.B.4
Weber, P.C.5
Force, T.6
Bonventre, J.V.7
-
46
-
-
0025390994
-
Mechanisms and therapy of myocardial reperfusion injury
-
46. Forman MB, Virmani R, Puett DW: Mechanisms and therapy of myocardial reperfusion injury. Circulation 81:IV69-IV78, 1990
-
(1990)
Circulation
, vol.81
-
-
Forman, M.B.1
Virmani, R.2
Puett, D.W.3
-
47
-
-
0027413809
-
Phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients
-
47. Haug CE, Colvin RB, Delmonico FL, Auchincloss H, Tolkoff-Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmidt L, Cosimi AB: Phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766-773, 1993
-
(1993)
Transplantation
, vol.55
, pp. 766-773
-
-
Haug, C.E.1
Colvin, R.B.2
Delmonico, F.L.3
Auchincloss, H.4
Tolkoff-Rubin, N.5
Preffer, F.I.6
Rothlein, R.7
Norris, S.8
Scharschmidt, L.9
Cosimi, A.B.10
|